vs

Astrana Health, Inc.(ASTH)与孩之宝(HAS)财务数据对比。点击上方公司名可切换其他公司

孩之宝的季度营收约是Astrana Health, Inc.的1.5倍($1.4B vs $950.5M),孩之宝净利率更高(13.9% vs 0.7%,领先13.3%),Astrana Health, Inc.同比增速更快(42.9% vs 31.3%),孩之宝自由现金流更多($389.5M vs $-6.0M),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs 38.2%)

Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。

孩之宝是1923年12月6日成立的美国跨国玩具制造与娱乐控股企业,总部位于罗德岛州波塔基特。旗下拥有Kenner、米尔顿·布拉德利、派克兄弟、威世智等知名品牌,持有大量热门IP商标权,业务覆盖玩具生产、游戏开发、娱乐内容出品等多个领域。

ASTH vs HAS — 直观对比

营收规模更大
HAS
HAS
是对方的1.5倍
HAS
$1.4B
$950.5M
ASTH
营收增速更快
ASTH
ASTH
高出11.6%
ASTH
42.9%
31.3%
HAS
净利率更高
HAS
HAS
高出13.3%
HAS
13.9%
0.7%
ASTH
自由现金流更多
HAS
HAS
多$395.4M
HAS
$389.5M
$-6.0M
ASTH
两年增速更快
ASTH
ASTH
近两年复合增速
ASTH
53.3%
38.2%
HAS

损益表 — Q4 FY2025 vs Q4 FY2025

指标
ASTH
ASTH
HAS
HAS
营收
$950.5M
$1.4B
净利润
$6.6M
$201.6M
毛利率
68.7%
营业利润率
1.9%
20.6%
净利率
0.7%
13.9%
营收同比
42.9%
31.3%
净利润同比
184.4%
687.8%
每股收益(稀释后)
$0.12
$1.46

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
ASTH
ASTH
HAS
HAS
Q4 25
$950.5M
$1.4B
Q3 25
$956.0M
$1.4B
Q2 25
$654.8M
$980.8M
Q1 25
$620.4M
$887.1M
Q4 24
$665.2M
$1.1B
Q3 24
$478.7M
$1.3B
Q2 24
$486.3M
$995.3M
Q1 24
$404.4M
$757.3M
净利润
ASTH
ASTH
HAS
HAS
Q4 25
$6.6M
$201.6M
Q3 25
$373.0K
$233.2M
Q2 25
$9.4M
$-855.8M
Q1 25
$6.7M
$98.6M
Q4 24
$-7.8M
$-34.3M
Q3 24
$16.1M
$223.2M
Q2 24
$19.2M
$138.5M
Q1 24
$14.8M
$58.2M
毛利率
ASTH
ASTH
HAS
HAS
Q4 25
68.7%
Q3 25
70.1%
Q2 25
77.0%
Q1 25
76.9%
Q4 24
67.4%
Q3 24
70.4%
Q2 24
76.1%
Q1 24
73.0%
营业利润率
ASTH
ASTH
HAS
HAS
Q4 25
1.9%
20.6%
Q3 25
2.0%
24.6%
Q2 25
3.1%
-81.4%
Q1 25
3.3%
19.2%
Q4 24
0.1%
5.4%
Q3 24
5.9%
23.6%
Q2 24
6.2%
21.3%
Q1 24
7.5%
15.3%
净利率
ASTH
ASTH
HAS
HAS
Q4 25
0.7%
13.9%
Q3 25
0.0%
16.8%
Q2 25
1.4%
-87.3%
Q1 25
1.1%
11.1%
Q4 24
-1.2%
-3.1%
Q3 24
3.4%
17.4%
Q2 24
3.9%
13.9%
Q1 24
3.7%
7.7%
每股收益(稀释后)
ASTH
ASTH
HAS
HAS
Q4 25
$0.12
$1.46
Q3 25
$0.01
$1.64
Q2 25
$0.19
$-6.10
Q1 25
$0.14
$0.70
Q4 24
$-0.14
$-0.25
Q3 24
$0.33
$1.59
Q2 24
$0.40
$0.99
Q1 24
$0.31
$0.42

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
ASTH
ASTH
HAS
HAS
现金及短期投资手头流动性
$429.5M
总债务越低越好
股东权益账面价值
$779.3M
$565.5M
总资产
$2.2B
$5.6B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
ASTH
ASTH
HAS
HAS
Q4 25
$429.5M
Q3 25
$463.4M
Q2 25
$342.1M
Q1 25
$260.9M
Q4 24
$290.8M
Q3 24
$350.3M
Q2 24
$327.7M
Q1 24
$337.3M
股东权益
ASTH
ASTH
HAS
HAS
Q4 25
$779.3M
$565.5M
Q3 25
$775.5M
$433.8M
Q2 25
$765.5M
$269.7M
Q1 25
$745.4M
$1.2B
Q4 24
$712.7M
$1.2B
Q3 24
$704.6M
$1.3B
Q2 24
$678.9M
$1.2B
Q1 24
$653.5M
$1.0B
总资产
ASTH
ASTH
HAS
HAS
Q4 25
$2.2B
$5.6B
Q3 25
$2.2B
$5.5B
Q2 25
$1.4B
$5.2B
Q1 25
$1.3B
$6.0B
Q4 24
$1.4B
$6.3B
Q3 24
$1.3B
$7.2B
Q2 24
$1.3B
$6.9B
Q1 24
$1.2B
$6.2B

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
ASTH
ASTH
HAS
HAS
经营现金流最新季度
$-2.9M
$403.2M
自由现金流经营现金流 - 资本支出
$-6.0M
$389.5M
自由现金流率自由现金流/营收
-0.6%
26.9%
资本支出强度资本支出/营收
0.3%
0.9%
现金转化率经营现金流/净利润
-0.44×
2.00×
过去12个月自由现金流最近4个季度
$104.5M
$829.9M

8季度趋势,按日历期对齐

经营现金流
ASTH
ASTH
HAS
HAS
Q4 25
$-2.9M
$403.2M
Q3 25
$10.0M
$280.6M
Q2 25
$90.9M
$71.3M
Q1 25
$16.6M
$138.1M
Q4 24
$-10.9M
$259.8M
Q3 24
$34.0M
$222.5M
Q2 24
$23.2M
$187.3M
Q1 24
$6.0M
$177.8M
自由现金流
ASTH
ASTH
HAS
HAS
Q4 25
$-6.0M
$389.5M
Q3 25
$7.4M
$260.9M
Q2 25
$89.5M
$55.2M
Q1 25
$13.6M
$124.3M
Q4 24
$-13.5M
$200.8M
Q3 24
$31.7M
$174.0M
Q2 24
$20.4M
$135.4M
Q1 24
$5.6M
$132.0M
自由现金流率
ASTH
ASTH
HAS
HAS
Q4 25
-0.6%
26.9%
Q3 25
0.8%
18.8%
Q2 25
13.7%
5.6%
Q1 25
2.2%
14.0%
Q4 24
-2.0%
18.2%
Q3 24
6.6%
13.6%
Q2 24
4.2%
13.6%
Q1 24
1.4%
17.4%
资本支出强度
ASTH
ASTH
HAS
HAS
Q4 25
0.3%
0.9%
Q3 25
0.3%
1.4%
Q2 25
0.2%
1.6%
Q1 25
0.5%
1.6%
Q4 24
0.4%
5.4%
Q3 24
0.5%
3.8%
Q2 24
0.6%
5.2%
Q1 24
0.1%
6.0%
现金转化率
ASTH
ASTH
HAS
HAS
Q4 25
-0.44×
2.00×
Q3 25
26.69×
1.20×
Q2 25
9.65×
Q1 25
2.48×
1.40×
Q4 24
Q3 24
2.11×
1.00×
Q2 24
1.21×
1.35×
Q1 24
0.40×
3.05×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

HAS
HAS

Grow Brands$1.1B75%
Optimize Brands$188.7M13%
Digital And Licensing Gaming$135.7M9%
Class Of Principal Product Family Brands$13.1M1%
Filmand TV$2.4M0%

相关对比